Mark C. Kraus
Plus aucun poste en cours
Profil
Mark C.
Kraus formerly worked at Honeywell, Inc., as Principal from 1987 to 1990, Enpath Medical, Inc., as Vice President & General Manager-Introducers, Integer Holdings Corp., as Principal, r4 Vascular, Inc., as Vice President-Operations & Finance, and GV Medical, Inc., as Principal from 1990 to 1992.
Mr. Kraus received his undergraduate degree from the University of Minnesota.
Anciens postes connus de Mark C. Kraus
Sociétés | Poste | Fin |
---|---|---|
GV Medical, Inc. | Corporate Officer/Principal | 01/01/1992 |
Honeywell, Inc.
Honeywell, Inc. Aerospace & DefenseElectronic Technology Honeywell, Inc. manufactured integrated and provided civil and military avionics and other aerospace products and service for homes, commercial and aviation industries. The company was headquartered in Minneapolis, MN | Corporate Officer/Principal | 01/01/1990 |
INTEGER HOLDINGS CORPORATION | Corporate Officer/Principal | - |
r4 Vascular, Inc.
r4 Vascular, Inc. Medical/Nursing ServicesHealth Services r4 Vascular combines innovative design and manufacturing with an intimate knowledge of the needs of patients, oncologists, interventional radiologists, surgeons, and nurses to create premium vascular access products. Its products help clinician's access patient vasculature, and effectively maintain access for delivering chemotherapy, blood products, antibiotics, drugs or nutrition. r4 Vascular is in Minnesota's Life Sciences Alley with a high concentration of medical technology companies. Their people represent decades of experience in the medical device industry, with unrivaled experience and insight in vascular access. r4 Vascular is driving innovation in vascular access medical technology. Their passion is 'uncomplicating' venous access, chemotherapy, and drug delivery. Its product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help its catheters remain patent and effective. | Directeur Financier/CFO | - |
Enpath Medical, Inc.
Enpath Medical, Inc. Medical SpecialtiesHealth Technology Enpath Medical, Inc. designs, develops, manufactures and markets single use medical device products. The company was founded in 1985 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Formation de Mark C. Kraus
University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INTEGER HOLDINGS CORPORATION | Health Technology |
Entreprise privées | 4 |
---|---|
Enpath Medical, Inc.
Enpath Medical, Inc. Medical SpecialtiesHealth Technology Enpath Medical, Inc. designs, develops, manufactures and markets single use medical device products. The company was founded in 1985 and is headquartered in Minneapolis, MN. | Health Technology |
GV Medical, Inc. | Health Technology |
Honeywell, Inc.
Honeywell, Inc. Aerospace & DefenseElectronic Technology Honeywell, Inc. manufactured integrated and provided civil and military avionics and other aerospace products and service for homes, commercial and aviation industries. The company was headquartered in Minneapolis, MN | Electronic Technology |
r4 Vascular, Inc.
r4 Vascular, Inc. Medical/Nursing ServicesHealth Services r4 Vascular combines innovative design and manufacturing with an intimate knowledge of the needs of patients, oncologists, interventional radiologists, surgeons, and nurses to create premium vascular access products. Its products help clinician's access patient vasculature, and effectively maintain access for delivering chemotherapy, blood products, antibiotics, drugs or nutrition. r4 Vascular is in Minnesota's Life Sciences Alley with a high concentration of medical technology companies. Their people represent decades of experience in the medical device industry, with unrivaled experience and insight in vascular access. r4 Vascular is driving innovation in vascular access medical technology. Their passion is 'uncomplicating' venous access, chemotherapy, and drug delivery. Its product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help its catheters remain patent and effective. | Health Services |